TP53 and neoplasm: Using an in vitro ganglion + tumor cell assay, some tumor cells could promote neuritogenesis better than others; a common feature among those cells was the loss of p53, and this held true in murine studies, even in a pre-malignant stage prior to cancer cell/neuron contact.